Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Misses on EPS, Stock Up 0.84%

Corvus Pharmaceuticals reported a loss of $0.43 per share, but the stock still saw a modest increase of 0.84%. This reaction may indicate that investors were not overly concerned about the earnings miss, possibly due to a lack of expectations or other factors not disclosed in the call. Without further guidance or commentary from management, the future outlook remains uncertain.